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Over 2100 induction time experiments were carried out for the medium-sized,
antipsychotic drug molecule, risperidone in seven diﬀerent organic solvents. To reach
the same induction time the required driving force increases in the order: cumene,
toluene, acetone, ethyl acetate, methanol, propanol, and butanol, which reasonably well
correlates to the interfacial energies as determined within classical nucleation theory.
FTIR spectroscopy has been used to investigate any shifts in the spectra and to estimate
the interaction of solute and solvent at the corresponding site. The solution condition
has also been investigated by Density Functional Theory (DFT) calculations over (1 : 1)
solvent–solute binding interactions at 8 diﬀerent sites on the risperidone molecule. The
DFT computational results agree with the spectroscopic data suggesting that these
methods do capture the binding strength of solvent molecules to the risperidone
molecule. The diﬃculty of nucleation correlates reasonably to the DFT computations
and the spectroscopic measurements. The results of the diﬀerent measurements
suggest that the stronger the solvent binds to the risperidone molecule in solution, the
slower the nucleation becomes.1. Introduction
Crystal nucleation from solution is a key step in crystallization processes and
solution crystallization is widely used in the pharmaceutical, food, chemical and
agrochemical industries. Crystal nucleation is inuenced by the solvent and
within the Classical Nucleation Theory (CNT) framework this is captured in the
interfacial energy1,2 and in the pre-exponential factor.3 The inuence on the
kinetics of nucleation is assumed to be partly related to an inuence on the type
and the size of molecular assemblies (clusters) in the solution. Solution struc-
turing of solute molecules has been investigated by various spectroscopicaMaterials and Surface Science Institute, Chemical and Environmental Science Department, University of
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View Article Onlinemethods (IR,4 Raman,5 NMR,6 UV-visible7) to establish a link with the crystal
structure of the nucleating solid phase. In some cases such a link could be
established and in others cases not.8,9 In addition to the type of aggregates6,10 in
the solutions, the type of solvent–solute interaction can also dictate the
morphology11 as well as the kinetics of nucleation.12 Lohani et al.13 showed the
type of solvent–solute interaction aﬀecting the diﬀusion coeﬃcient, resulting in
the preferential crystallization of one form over another. The hydrogen bonding
capabilities of a solvent and the nature of interaction prevailing between solute
and solvent resulting in the nucleation of a particular form has also been a subject
of a number of studies.5,14
Application of the CNT framework on experimentally measured nucleation
rate data helps to determine the nucleation work and the interfacial energy in
diﬀerent solvents. The inuence of solvent on the ease or diﬃculty of nucleation
can be used to probe the nucleation process on the molecular level. Our previous
work12 on a small molecule, salicylic acid (138.12 g mol1) reveals the role of the
solvent in the nucleation of this compound. By employing solution calorimetry,
vibrational spectroscopy and quantum-chemical calculations over one-to-one
solvent–solute molecule interactions as well as over the complete rst solvation
shell, it was consistently observed that the stronger the solvent binds to salicylic
acid, the greater is the diﬃculty of nucleation. On a similar note, the eﬀect of
solvent was also recently highlighted by Sullivan et al.15 in which the authors
suggest the process of desolvation aﬀects the kinetics of nucleation and thus
governs the nucleation process. Zhao et al.16 studied the eﬀect of solvent on the
crystallization of nesquehonite (MgCO3$2H2O). They reported faster nucleation
kinetics with the addition of dimethyl formamide (DMF) to the water which they
attributed to the kinetic factors accelerating the cluster aggregation in a non-
classical mechanism.
In spite of the critical importance of the choice of solvent in solution crystal-
lization, there is only a limited amount of nucleation rate data available for
medium- to large-sized organic molecules in a range of organic solvents. Much of
the previously published work is carried out either in one solvent only or for
small-sized molecules only. The size and complexity of the solute molecule can
certainly add complications to an already complex nucleation process. In this
work, we use a medium sized (410.49 g mol1), fairly complex and conforma-
tionally exible pharmaceutical molecule (API), risperidone, and use the inu-
ence of the solvent as a probe to investigate the mechanisms of nucleation. The
results are analysed directly without the use of the CNT framework as well as
within that framework. The strength of solvent–solute interaction is quantied
using DFT calculations and is examined by solution spectroscopy for particularFig. 1 Molecular structure of risperidone.
310 | Faraday Discuss., 2015, 179, 309–328 This journal is © The Royal Society of Chemistry 2015
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View Article Onlineinteraction sites. The molecular structure of risperidone is shown in Fig. 1. There
are two reported polymorphs of risperidone and both structures, form I (WASTEP)
and form II (WASTEP01) are reported in the Cambridge Structure Database.2. Materials and methods
2.1. Materials
Risperidone (>99.95%), form I, was kindly provided by Janssen Pharmaceuticals,
Ireland, and used without further purication. All solvents were purchased from
VWR International; methanol (99.8% purity by volume), 1-propanol (99.8%), 1-
butanol (99.8%), ethyl acetate (99.8%), acetone (99.8%), toluene (99.8%), and
cumene (99.8%).2.2. Induction time measurement
The induction time of nucleation of risperidone was measured in seven solvent
systems with a saturation temperature of 50 C. Over 2160 nucleation events were
observed at 27 diﬀerent conditions.
Stock solutions were prepared in 500 ml sealed glass bottles by weighing
appropriate amounts of risperidone and solvent according to previously pub-
lished solubility data.9 An equilibration period of 12 h at 55 C was allowed, with
agitation provided with a PTFE (polytetrauoroethylene) coated magnetic stirrer
(38  10 mm, 3  11 mm pivot ring) at 500 rpm. Solutions were dispensed via
preheated syringes and 0.2 mm solvent compatible lters (PTFE or Nylon), into
twenty 20 ml glass vials (70 20 mm, VWR International). A magnetic stirring bar
(13 3 mm) was added to each vial prior to sealing with a plastic screw cap with a
PTFE seal. Solutions were then subjected to a second equilibration period at 55 C
overnight before the crystallization experiments were performed.
An experimental apparatus identical to that described by Mealey et al.17 was
employed to simultaneously monitor 20 individual nucleation experiments. Solu-
tions were transferred from bath A at 55 C to bath B held at a temperature where
the solutions were supersaturated (Tsupersat). Agitationwas provided at 400 rpm via a
60 point submersible magnetic stirring plate (2Mag). Immediately aer the trans-
fer, the time to nucleate (temperature equilibration time + isothermal nucleation
time) was measured with a high denition video camera observing the transition
from a clear to cloudy solution. The approach to temperature equilibrium was
measured separately with a control tube of pure solvent and an in situ calibrated
temperature probe (Dostmann P600). Once all tubes had nucleated they were
transferred back to water bath A where complete dissolution occurred and equili-
bration was allowed overnight. The cycle was repeated four times until approxi-
mately 80 nucleation events were recorded for a given driving force and solvent.
To avoid the possible eﬀects of degradation of the risperidone molecule each
batch of 20 tubes were subjected to just four temperature cycles. It was observed
that upon extended time at elevated temperature an obvious colour change would
occur in the solutions. A new batch of tubes was prepared for each separate
driving force. Along with monitoring solutions visually, aer four cycles solutions
were spotted onto silica gel thin layer chromatography (TLC) plates using meth-
anol as a mobile phase and viewed under UV light to ensure there were no
detectable impurities.This journal is © The Royal Society of Chemistry 2015 Faraday Discuss., 2015, 179, 309–328 | 311
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View Article OnlineSolid samples were isolated by ltration, moments aer nucleation for both an
early nucleation and a late nucleation event, at both high and low driving forces.
The polymorphic form was determined by reectance powder X-ray diﬀraction
(PXRD, Philips PANalytical X'Pert MP PRO) in the range 5–35 (2q) with a wave-
length of 1.54 A˚ (40 kV, 35 mA). In all cases the solid phase analysed was pure
form I. The theoretical PXRD patterns generated from the crystallographic
information les for both form I and form II along with the samples taken from
risperidone nucleation in toluene are shown in the ESI.†2.3. Computational methods
Density Functional Theory (DFT) calculations have been applied to investigate
(1 : 1) solvent–solute pair interactions. For this purpose, a risperidone molecule
has been extracted from the crystal lattice of its form I (WASTEP) and optimized in
isolation at the B97-D3/6-31G(d,p) level. The molecular geometry changed only
slightly upon gas-phase optimization, preserving the original crystal-like confor-
mation (cf. Fig. S4, ESI†). The seven solvents used in our experimental work can be
divided into three groups: polar protic (alcohols), polar aprotic (acetone and ethyl
acetate), and nonpolar (toluene and cumene). Three solvents (one from each
group), representing diﬀerent polarity and H-bond capability, were chosen for the
modelling part, i.e. 1-propanol, acetone, and toluene. These solvents posses
diﬀerent bonding mechanisms. 1-Propanol is both a H-bond donor and acceptor,
acetone is only capable of accepting H-bonds, while toluene is not capable of
making strong H-bonds, although it can interact through p-electrons located over
its benzene ring. The (1 : 1) solvent–solute interactions are probed at eight sites of
the risperidone molecule chosen with aid of the electrostatic potential map (EPM)
as shown in Fig. 2. The EPM indicates higher electron deciency (dark blue
colour) at the hydrogens labelled H1, H2, and H3, while the electron rich regions,
having H-bond accepting capabilities, are highlighted in red/yellow at the
heteroatoms O1, O2, and N1–N3 (Fig. S2, ESI,† shows more projections of the
EPM). Based on the electron distribution, one can expect that in the crystal, the
higher electron deciency at the ring 1 hydrogens will be complemented by
neighbouring electron rich polar atoms resulting in relatively strong intermo-
lecular bonding. This can indeed be observed in the risperidone crystal structure
(cf. Fig. 2b) and thus validates the electrostatic potential map presented.
The considered eight sites represent all the important binding features of the
risperidone molecule such as interaction at (i) polar sites containing O and N
heteroatoms (H-bond acceptors; sites 3, 5, and 7), (ii) non-polar C–H-terminated
sites 1 and 8, and (iii) the connected rings 1–2 (site 4) and 4–5 (site 6). In addition,
for all the seven solvents we have modelled the (1 : 1) risperidone–solvent asso-
ciates at site 5; this site combines two electron-rich atoms, i.e. carbonyl oxygen
and tertiary amine nitrogen, and thus it is expected to yield strong interactions.
Another reason for choosing site 5 was the ability of comparing the calculated
solvent–solute binding energies of the risperidone carbonyl group across all the
seven solvents with the respective experimentally determined C]O shis in the
FTIR spectrum.
The equilibrium geometries of the (1 : 1) dimers are calculated with a B97-D3
Grimme's functional,18 and a Gaussian-type 6-31G(d,p) basis set.19 Binding
energies in the dimers are calculated for the lowest energy congurations, aer312 | Faraday Discuss., 2015, 179, 309–328 This journal is © The Royal Society of Chemistry 2015
Fig. 2 Molecular arrangement in the risperidone crystal (a); chief interactions and inter-
molecular distances (in Angstroms) between molecules neighbouring in a monolayer (b);
electrostatic potential isosurface and deﬁnition of interaction sites in risperidonemolecule
for probing solvent–solute bonding (c) (blue – positive, red – negative, green – neutral
potential).
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View Article Onlineprobing a set of sensible molecular orientations, using a double hybrid B2PLYP-
D3 functional,20 which combines exact Hartree–Fock exchange with an MP2-like
correlation and long-range dispersion corrections; here we use a basis set of
quadruple-z valence quality (def2-QZVP).21 The binding energy is calculated as
follows:
DEbind ¼ EA–B  (EA + EB) (1)This journal is © The Royal Society of Chemistry 2015 Faraday Discuss., 2015, 179, 309–328 | 313
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View Article Onlinewhere EA–B is the energy of a dimer and EA and EB are the energies of isolated
monomers A and B in fully relaxed gas phase geometries.
Conformational analysis of the risperidone molecule has been carried out at
the DFT B97-D3/6-31G(d,p)//B2PLYP-D3/def2-QZVP level (gas-phase, 0 K), with
energy barriers to rotation calculated for four rotational centres (single bonds) of
the risperidone molecule (Fig. S5, ESI†). We restricted our calculations to elec-
tronic energies only (corrections for zero point energy and other vibrational
contributions are not included). A relaxed potential energy surface (PES) scan over
360, with the step interval of 5, has been performed for the respective dihedral
angles. Four new low energy conformers were identied upon PES scanning and
their stabilities have been compared relative to the relaxed crystal-like
conformation.
Calculations were performed using the GAUSSIAN 09 package.22 Electrostatic
potential maps were generated with the MOLEKEL 5.4 soware.232.4. Spectroscopic methods
Solution spectroscopy was carried out for risperidone in all the seven solvents that
were used for nucleation work. Raman spectra were collected using Kaiser Raman
Rxn2 analyser with an Invictus 785 nm excitation laser. For liquid samples, a short
focus immersion probe of 1/4 inch diameter was used and the solid samples were
analysed using a non-contact optic probe. Each spectrum was collected for a
minimum of 15 s exposure time and ve accumulations in the spectral region of
3400–200 cm1 using Mettler Toledo iC Raman soware version 4.1.
IR spectrum of the solid material was collected using Perkin Elmer spectrum
100 spectrometer with Universal ATR accessory in the spectral region of 4000–650
cm1 with 4 cm1 resolution. IR spectra of solutions were collected using Mettler
Toledo ReactIR 10 tted with a bre optic probe and a diamond composite tip.
Due to the nature of the bre optic probe, the solution spectra were collected in
the ngerprint region of 2000–650 cm1 with 4 cm1 resolution using iC IR
soware version 4.3. All the spectral data were collected at ambient temperature
(20–22 C).3. Results
3.1. Rate of nucleation in diﬀerent solvents
Induction time distributions from toluene (a) and ethyl acetate (b) are shown in
Fig. 3.
The use of various distribution functions to examine induction time data has
previously been examined.17,24 Here we have used the lognormal cumulative
distribution function (LCDF) and the exponential-based function of Jiang and ter
Horst.24 Both distributions provide reasonably similar ts to the data, and results
are collected in Table 1. The calculated nucleation rates using both methods
display similar trends with driving force. Fitting the LCDF produced coeﬃcients
of determination greater than 0.97 in all instances while the ts of the exponential
function were similar with one exception resulting in a coeﬃcient of determi-
nation of 0.94.
The tting to the LCDF includes no assumption of a particular mechanism of
nucleation. By examining the relation of the induction time distributions to the314 | Faraday Discuss., 2015, 179, 309–328 This journal is © The Royal Society of Chemistry 2015
Fig. 3 Induction time distributions from toluene (a) and ethyl acetate (b) at various driving
forces. Also shown is the ﬁt of the LCDF (solid lines) and the exponential distribution
function24 (dashed lines).
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View Article Onlinedriving force in Fig. 4 across the various solvents, it is obvious that nucleation is
faster in non-polar (toluene and cumene) and polar aprotic (acetone and ethyl
acetate) solvents than in the alcohols (1-propanol, methanol, and butanol). To
reach equal median induction time, in the range where data is available for all
solvents, the driving force required increases in the order: cumene, toluene,
acetone, ethyl acetate, methanol, propanol and butanol (Table 2).
Based on the geometric mean induction times reported in Table 1, Fig. 5
presents the standard plot for evaluation of the induction time data within the
classical nucleation theory. By relating the induction time (tind) to the nucleation
rate (J) it is possible to estimate the pre-exponential factor (A) and the interfacial
energy (4) using eqn (2) and (3):
1
tindV
¼ J ¼ A exp
DGcrit
R T

(2)
DGcrit ¼ 16pNA4
3y2
3ðRT ln SÞ2 (3)This journal is © The Royal Society of Chemistry 2015 Faraday Discuss., 2015, 179, 309–328 | 315
Table 1 Parameters describing induction time distributions of risperidone in various
solvents from ﬁtting the lognormal distribution function (geometric mean (h*), geometric
standard deviation (s*), calculated nucleation rate (J), and size of the critical nucleus (N*),
or exponential based function24 (nucleation rate (Ja))
Solvent RT ln S [J mol1] h* (s) ∕ s* J (m3 s1) N* Ja (m3 s1)
Cumene 757 4682 ∕ 3.75 10.68 24 6.67
940 1343 ∕ 1.93 37.25 13 43.48
1120 732 ∕ 1.83 68.29 7 87.22
Toluene 762 7397 ∕ 2.84 6.76 23 4.78
952 2286 ∕ 3.24 21.87 12 14.28
1406 886 ∕ 3.15 56.44 4 38.00
1664 489 ∕ 2.19 102.28 2 105.12
Acetone 526 18374 ∕ 3.22 2.72 78 1.99
858 5528 ∕ 2.36 9.05 18 7.43
1074 2472 ∕ 2.02 20.23 9 18.25
1287 1036 ∕ 2.17 48.28 5 46.65
Ethyl acetate 807 6914 ∕ 2.21 7.23 15 6.05
1008 3666 ∕ 2.55 13.64 8 10.78
1204 2247 ∕ 2.20 22.25 5 21.16
1491 1265 ∕ 2.17 39.51 2 37.46
Methanol 1338 3166 ∕ 2.07 15.79 9 14.66
1553 2289 ∕ 2.68 21.85 6 16.42
1897 1514 ∕ 3.45 33.02 3 20.20
2224 673 ∕ 2.41 74.31 2 64.33
1-Propanol 1072 16549 ∕ 3.52 3.02 19 1.81
1632 3216 ∕ 3.43 15.55 5 9.54
2013 1172 ∕ 2.76 42.65 3 31.99
2378 654 ∕ 2.39 76.48 2 68.52
Butanol 1377 4362 ∕ 2.86 11.46 6 8.41
1654 2963 ∕ 2.51 16.88 4 13.84
2025 2262 ∕ 2.52 22.10 2 18.97
2370 1239 ∕ 2.01 40.37 1 42.53
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View Article Onlinewhere NA is the Avogadro number, R is the gas constant, T is temperature, DGcrit is
the nucleation work assuming a spherical nucleus, V is the volume of the solution,
y is the molar volume of risperidone in the cluster, and RT ln S is the supersat-
uration driving force where S is the supersaturation ratio in terms of the mole
fraction. The solid liquid interfacial energies and the preexponential factors are
reported in Table 3.
No direct relation can be found between the interfacial energy in the
diﬀerent solvents and the solid–liquid solubility, regardless of units of the
latter which agrees with our previous ndings.3,12,25 There is neither a clear
correlation with the Hansen solubility parameter nor with the viscosity of the
solvent.316 | Faraday Discuss., 2015, 179, 309–328 This journal is © The Royal Society of Chemistry 2015
Fig. 4 Induction time distributions. Data points represent the geometric mean (h*) of the
LCDF while the shaded regions represent one geometric standard deviation (s*) from this
mean.
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View Article Online3.2. DFT calculations
By running the potential energy surface scan over the dihedral angles of the four
single bonds that serve as rotational centres, we have found that the relevant
energy barriers to interconversion between the diﬀerent conformational isomers
range from 10 kJ mol1 to 26 kJ mol1 (ESI†). There is one new isomer identied
for each rotational centre being structurally diﬀerent from those constituting
known conformations in the crystal structure of risperidone form I (and form II).
Three of the new conformers are linear and the fourth is U-shaped. Two of the
linear conformers are slightly more stable (lower in energy by 2–3 kJ mol1), while
the U-shaped molecule is higher in energy by 6.3 kJ mol1 as compared to theTable 2 A quantiﬁed measure of the ease of nucleation of risperidone in 7 diﬀerent
solvents
Solvent
Driving force (RT ln S, J
mol1) required to reach
median induction time
Driving force order2000 s 3000 s
Cumene 854 784 1
Toluene 1015 841 2
Acetone 1055 954 3
Ethyl acetate 1288 1112 4
Methanol 1639 1370 5
Propanol 1829 1657 6
Butanol 1976 1671 7
This journal is © The Royal Society of Chemistry 2015 Faraday Discuss., 2015, 179, 309–328 | 317
Fig. 5 Log geometric mean induction times plotted against driving force to determine the
interfacial energy and preexponential factor within classical nucleation theory.
Faraday Discussions Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
3 
Fe
br
ua
ry
 2
01
5.
 D
ow
nl
oa
de
d 
on
 8
/2
2/
20
18
 1
2:
09
:3
7 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinecrystal-like starting conformer; this suggests the least favourable geometry. It can
be assumed that only kinetically stable conformers, i.e. those separated by higher
energy barriers, could signicantly aﬀect the nucleation process. The relatively
low rotational barriers along with small energy diﬀerences of the three gas-phase
linear conformations vs. the crystal structure conformations indicate absence of
one kinetically stable conformation that could be unambiguously chosen as a
model conformation to study interactions of risperidone with solvent molecules.
For this reason, the linear conformation appearing in the crystal structure of
risperidone is used consistently in our modelling work. The calculated low energy
barriers to rotation indicate high conformational exibility of the risperidone
molecule and suggest a variety of diﬀerent conformations are present in solution.
The relatively large and complex risperidone molecule can possess a variety of
binding congurations with solvent molecules. Here we consider eight binding
sites, where the interactions at the risperidone molecule are probed with threeTable 3 Experimental solid–liquid interfacial energy and preexponential factor of ris-
peridone nucleation in the diﬀerent solvents. Also given is the solubility as mole fraction
(MF) and mol l1 at 25 C, as well as the Hansen solubility parameter c12 and the solvent
viscosity
Solvent
Driving force
order from
Table 2
Interfacial
energy
(mJ m2)
Pre-
exponential
factor,
A (m3 s1)
Solubility at 25 C
c12
Solvent
viscosity
(mPa S)(MF  103) (mol l1)
Cumene 1 1.72 348 2.60 18.68 2.05 0.78
Toluene 2 1.70 181 6.67 63.17 1.43 0.59
Acetone 3 1.77 161 1.75 23.79 1.18 0.31
Ethyl acetate 4 1.58 71 2.16 22.01 1.32 0.426
Methanol 5 2.18 134 3.96 98.12 1.44 0.59
1-Propanol 6 2.25 129 3.05 40.86 1.35 1.94
Butanol 7 2.04 61 3.47 38.01 1.46 2.54
318 | Faraday Discuss., 2015, 179, 309–328 This journal is © The Royal Society of Chemistry 2015
Fig. 6 Optimized geometry of risperidone–1-propanol, risperidone–acetone, and ris-
peridone–toluene (1 : 1) molecular associates (B97-D3/6-31G(d,p) level). Binding energy
in kJ mol1, calculated at B2PLYP-D3/def2-QZVP level. Hydrogen –white, carbon – grey,
oxygen – red, nitrogen – blue, ﬂuorine – pale blue.
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View Article Onlinerepresentative solvents, i.e. 1-propanol, acetone and toluene. The DFT binding
energy is calculated for each of the 24 solvent–solute (1 : 1) heterodimers (Fig. 6).
One solvent molecule can interact with a number of atoms of the risperidone
molecule. In case of site 1 and site 8, only C–Hhydrogens are involved in bonding.
The other sites feature a combined interaction of hydrogens and heteroatoms.This journal is © The Royal Society of Chemistry 2015 Faraday Discuss., 2015, 179, 309–328 | 319
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View Article OnlineOur calculations indicate that 1-propanol does not establish strong bonding at
the nonpolar sites 1 and 8 of risperidone, being up to 30% weaker than the
respective bonding to acetone and toluene. However, the propanol molecule
binds stronger at sites 3–7, where it forms H-bonds with polar heteroatoms of the
solute molecule. The strongest binding of 26.9 kJ mol1 and 26.3 kJ mol1 is
observed for site 7 and 5, respectively. The interaction at site 2, which combines
binding to hydrogen and uorine ring atoms, is relatively weak and decreases in
order: acetone > 1-propanol > toluene. Acetone and toluene molecules yield the
strongest binding of 19.5 kJ mol1 and 13.8 kJ mol1, respectively, when
placed over rings 4–5 (site 6). The solvent–risperidone (1 : 1) binding energies
averaged over the eight sites form an order: 1-propanol (16.2 kJ mol1) > acetone
(12.8 kJ mol1) > toluene (8.2 kJ mol1).
When comparing all the eight interaction sites it appears that site 5 is amongst
the strongest interacting sites. This site provides a set of polar groups, including
carbonyl oxygen and tertiary amine nitrogen, which result in strong binding with
a solvent molecule. In order to compare strength of the risperidone–solvent
interaction for all the seven solvents, the site 5 was chosen, and the respective
binding energies are shown in Fig. 7.
The binding energies calculated at site 5 form three distinct groups of
comparable values: (i) alcohols, yielding very similar and the strongest binding
interactions, (ii) acetone and ethyl acetate, with moderate binding, and (iii)
cumene and toluene, being relatively weakly bound to the risperidone molecule.3.3. Solution spectroscopy
Solid state spectra. IR and Raman spectra of risperidone form I are shown in
Fig. 8. In the ngerprint region carbonyl stretching appears as a strong peak at
1643 cm1 in the IR spectra, whereas in the Raman spectra it is only of moderate
intensity. In the crystal structure of form I the carbonyl is attached to three
diﬀerent C–H sites through weaker interaction and the interaction at the carbonyl
site roughly corresponds to the interaction at site 5 of the risperidone molecule
(Fig. 2). Apart from the dominant carbonyl peak, the ngerprint region shows a
strong peak at 1534 cm1 corresponding to mainly v(C4]N3, C1]C2)26 in the
pyrimidine ring (ring 4) and also some contribution from v(C1–N3) of the same
ring (cf. Fig. 2). Functional groups responsible for this vibration frequency
correspond to site 7 as shown in Fig. 2.
Solution spectra. For solution spectroscopy of this compound, IR spectroscopy
was found to be more suitable than Raman spectroscopy due to the low solubility
in the diﬀerent solvents leading to a weak solute signal in the Raman spectra. The
biggest diﬀerence in the solution spectra was observed for the carbonyl peak. In
case of alcoholic solutions this peak is marginally shied to 1648 cm1 followed
by higher shis in acetone and further shis in ethyl acetate, toluene and cumene
(Fig. 9). The shi in the carbonyl frequency follows the polarity order27 of the
solvents: alcohols > acetone > ethyl acetate > methyl benzenes (toluene and
cumene). The carbonyl stretching frequency, v(C]O) is sensitive to hydrogen
bonding and other solvent–solute interactions due to the eﬀect of interacting
species on the double bond characteristics of the carbonyl bond. The v(C]O), has
oen been used as a probe to study the solvent–solute interaction12,28,29 and
generally the stronger the solvent interacts, the lower the frequency at which it320 | Faraday Discuss., 2015, 179, 309–328 This journal is © The Royal Society of Chemistry 2015
Fig. 7 Risperidone–solvent (1 : 1) associates at site 5, with all the seven solvents used in
the experiment (B97-D3/6-31G(d,p) level). Binding energy in kJ mol1, calculated at
B2PLYP-D3/def2-QZVP level.
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View Article Onlineabsorbs. The shis of the carbonyl frequency suggest that at site 5 of the ris-
peridone molecule (Fig. 2) the alcohols are strongly bound followed by acetone
and ethyl acetate, and the methyl benzenes (toluene and cumene) are relatively
weakly interacting at this site.
Similar to the carbonyl peak, shis were also observed for the peak (1534 cm1)
corresponding to site 7. This peak at 1534 cm1 (in solid material) moves to
somewhat higher frequency in alcoholic solutions (1536 cm1) followed by
slightly higher frequency in acetone solution (1538 cm1) and further higher
frequency (1540 cm1) in toluene, cumene and ethyl acetate solutions. TheFig. 8 IR (blue) and Raman (green) spectrum of risperidone Form I (solid).
This journal is © The Royal Society of Chemistry 2015 Faraday Discuss., 2015, 179, 309–328 | 321
Fig. 9 IR spectra of risperidone showing the peak shift observed in diﬀerent solvents. The
solvent spectrum is subtracted from the solution spectra.
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View Article Onlinerelative shi diﬀerence was smaller than that observed for the carbonyl peak
which is expected considering a higher force constant for carbonyl stretching
frequency over the frequency responsible for the peak at 1534 cm1 in IR. The
concentration eﬀect on the spectra was also analysed for toluene, 1-propanol,
methanol and acetone solutions: there was no clear diﬀerence in the spectra due
to the diﬀerent concentrations. Details of concentration and the wavenumber
accuracy are shown in the ESI† le.
4. Discussion
The induction time experiments reveal that in order to reach the same induction
time the required driving force increases in the order: cumene < toluene < acetone
< ethyl acetate < methanol < propanol < butanol. We will refer to this order as
increasing diﬃculty of nucleation, and point out that this observation is directly
extracted from the experimental work without assumption of a particular theory.
This work further shows that if the data are processed within the framework of the
classical nucleation theory the obtained interfacial energies increase in a similar
but not identical order. Overall, the diﬀerence in interfacial energy of risperidone
depending on the solvent is rather limited, spanning from 1.58 to 2.25 mJ m2 for
the seven solvents investigated. In the alcohols the value is clearly higher than in
the other four solvents, but within these two groups of solvents the diﬀerences are
relatively small. With respect to the experimental uncertainties we do not see a big
discrepancy between the driving force order and the interfacial energy order even
though we do want to point out the diﬀerence with respect to ethyl acetate in
particular. Furthermore, since the nucleation rate in the classical nucleation322 | Faraday Discuss., 2015, 179, 309–328 This journal is © The Royal Society of Chemistry 2015
Fig. 11 Relationship between driving force required to reach a median induction time of
2000 s and the FTIR vibrational frequency of the risperidone carbonyl group, site 5.
Fig. 10 Cross-validation of solvent–risperidone interactions: DFT binding energy vs. FTIR
vibrational frequency at (a) carbonyl v(C]O) (site 5) for all the 7 solvents and (b) v(C]N +
C]C) in ring 4 (site 7) for selected 3 solvents.
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View Article Online
Fig. 12 Relationship between driving force at median induction time of 2000 s and DFT
binding energy: (a) for seven solvents at site 5, and (b) averaged over eight interaction sites
considering three representative solvents.
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View Article Onlinetheory depends on the preexponential factor as well as the nucleation work, the
order of nucleation according to the driving force scale doesn't necessarily have to
correlate with the interfacial energy order.
Risperidone is a relatively large molecule (410.49 g mol1) that possesses
various functional groups of diﬀerent polarity, serving as sites for intermolecular
interactions. Because of this DFT simulation of the complete rst solvation shell10
becomes too demanding and we settled for simulating a number of one-to-one
molecule solvent–solute pairs. In Fig. 10 the spectroscopic results are compared
with the DFT-computed solvent–risperidone binding energies at the carbonyl
group (Fig. 10a) site 5 and the pyrimidine ring (Fig. 10b) site 7. Obviously, there is
a good correlation in the data from the two methods: with increasing binding
energy the carbonyl peak and the pyrimidine peak both shi towards lower
frequencies. The results of both methods suggest that the binding to the non-
polar solvents cumene and toluene, is quite weak, is somewhat stronger to the
aprotic solvents ethyl acetate and acetone, and clearly stronger than the alcohols.
Since the carbonyl site shows a relatively larger shi in solution spectra, as
compared to the (C]N, C]C) vibrations of ring 4, the carbonyl group appears a324 | Faraday Discuss., 2015, 179, 309–328 This journal is © The Royal Society of Chemistry 2015
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View Article Onlinerelatively more sensitive probe for investigating the solvent–solute interactions in
solution.
In Fig. 11 we examine the correlation between the driving force required to
reach a median induction time of 2000 s and the FTIR carbonyl peak frequency.
The overall trend is that the required driving force increases with decreasing peak
frequency suggesting that the crystal nucleation of risperidone becomes gradually
more diﬃcult the stronger the solvent binds to the carbonyl site. The correlation
rather clearly distinguishes between the non-polar solvents, the aprotic solvents
and especially the alcohols. It must be noted though that the correlation in Fig. 11
shows strength of solvent–solute interaction only at one site. However a similar
correlation could be observed for the shi in the pyrimidine ring vibrations
aﬀecting site 7 as well. Unfortunately, in the solution IR spectroscopy only certain
sites of interactions can be probed, and the resolution is somewhat limited for
solvents bearing similar structural features such as the group of alcohols and the
pair of toluene and cumene. This points out certain limitations of FTIR spec-
troscopy in such work.
Fig. 12a shows, as expected, that the nucleation driving force correlates nicely
with the DFT computed (1 : 1) binding energy to the carbonyl group at site 5. At
the sites where the DFT binding energies are the strongest, i.e. sites 5, 6, and 7,
we also observe a correlation between binding energy and the ease of nucleation
for the three considered solvents. It is noteworthy that, for ve sites out of the
eight considered, the binding energies follow the order of diﬃculty ofFig. 13 Relationship between interfacial energy and (a) driving force at median induction
time of 2000 s, (b) FTIR vibrational frequency of risperidone carbonyl group, (c) DFT
binding energy of solvent–solute at site 5 (purple diamonds) and site 7 (red dots), and (d)
DFT binding energy of solvent–solute as averaged over eight interaction sites. Cumene
(CU), toluene (TL), acetone (AC), ethyl acetate (EA), methanol (ME), propanol (PR), and
butanol (BU).
This journal is © The Royal Society of Chemistry 2015 Faraday Discuss., 2015, 179, 309–328 | 325
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View Article Onlinenucleation. The three sites where there is no such a correlation are those where
the solvent–solute interactions are relatively weak, as they feature either rela-
tively non-polar C–H hydrogens (site 1 and 8) or a combined interaction of
hydrogen and uorine (site 2). For the three solvents where we have DFT-
computed binding energies to all 8 sites, we have calculated a mean interaction
energy, and the correlation to the nucleation driving force is shown in Fig. 12b.
Based on these three solvents only the correlation is not overly impressive, since
the nucleation driving force required in acetone for 2000 s induction time is
almost the same as for toluene. It is noteworthy though that at 3000 s induction
time (Table 2), there is a somewhat more clear diﬀerence in driving force
between toluene and acetone.
Since oen the nucleation propensity is characterised by the interfacial energy
only, for completeness we also show the corresponding correlations in Fig. 13.
Fig. 13a shows the correlation between the interfacial energy and the driving force
required to induce the same induction time. Overall, the diﬀerence between the
alcohols and the other solvents is distinguished but the more detailed order
diﬀers, and in particular a discrepancy is observed in case of ethyl acetate, where
the lowest interfacial energy of 1.58 mJ m2 is calculated, despite the driving force
being somewhat in the mid-range (cf. Fig. 4 and Table 2). The correlations of
interfacial energy with carbonyl frequency (Fig. 13b), the DFT calculated binding
energies at sites 5 and 7 (Fig. 13c), and the average binding energy (Fig. 13d), are
similar to that shown in Fig. 13a. Overall, we observe that the strength of solvent–
solute interaction aﬀects the nucleation process, such that the stronger the
solvent binds to the solute, the greater the diﬃculty of nucleation becomes. This
very much follows the observations made for salicylic acid,13 further supporting
the hypothesis that desolvation of the solvent molecules during the process of
formation of crystal nuclei can be a key step in explaining the inuence of the
solvent on the nucleation process.5. Conclusions
The nucleation of risperidone depends on the solvent. To reach the same
induction time the required driving force increases in the order: cumene, toluene,
acetone, ethyl acetate, methanol, propanol, and butanol. This order overall
corresponds to the order of increasing interfacial energy as determined within the
classical nucleation theory, but there are deviations in the detailed order. The
frequency of the FTIR spectroscopy peaks corresponding to the carbonyl and
pyrimidine group vibrations decreases in the polarity order of the three solvent
groups. DFT (1 : 1) solvent–solute binding energies depend signicantly on the
binding site for all three solvents investigated. For the carbonyl site the binding
energy increases essentially in the same order as the order of increasing driving
force. A good correlation between spectroscopic data and DFT simulations
provides validation for the relevance of these techniques in characterising
solvent–solute interactions. The results of this work support the hypothesis that
the inuence of the solvent on the crystal nucleation is related to the desolvation
of the risperidone molecules. The stronger the solvent binds to the risperidone
molecule in solution, the more diﬃcult the desolvation and the slower the
nucleation becomes.326 | Faraday Discuss., 2015, 179, 309–328 This journal is © The Royal Society of Chemistry 2015
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